Ferraccioli G, Gremese E
Institute of Rheumatology, School of Medicine, Catholic University of the Sacred Heart, Rome, Italy.
Clin Exp Immunol. 2017 Dec;190(3):291-292. doi: 10.1111/cei.13039. Epub 2017 Sep 28.
Analysis of B cell activating factor (BAFF) receptors before and after B cell depletion therapy (BCDT) might offer a clue to the understanding of whether some B cell subsets may represent useful biomarkers of biological and clinical responses. Among the BAFF receptors in a cohort of rheumatoid arthritis (RA) patients, the AA have shown, by fluorescence activated cell sorter (FACS) analysis of median fluorescence intensity (MFI), that transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) and B cell maturation antigen (BCMA) do not change, whereas the most important, BAFF receptor 3 (BR3), appears to be decreased before as well as after BCDT in all B cell subsets but not in plasmablasts, the most important subset, depleted by BCDT.
在B细胞清除疗法(BCDT)前后分析B细胞活化因子(BAFF)受体,可能为理解某些B细胞亚群是否可作为生物学和临床反应的有用生物标志物提供线索。在一组类风湿性关节炎(RA)患者的BAFF受体中,AA通过对中位荧光强度(MFI)进行荧光激活细胞分选仪(FACS)分析表明,跨膜激活剂和钙调节亲环素配体相互作用分子(TACI)以及B细胞成熟抗原(BCMA)没有变化,而最重要的BAFF受体3(BR3)在所有B细胞亚群中,无论在BCDT之前还是之后似乎都有所降低,但在浆母细胞中没有降低,浆母细胞是BCDT清除的最重要亚群。